Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital. Stay tuned as we add new specialties.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Neuroscience
Mindfulness-based Cognitive Therapy Shows Promise for Treating Depression in Chronically Ill Patients
Mass General researchers were part of the first group to investigate whether mindfulness-based cognitive therapy might relieve depression in people with chronic pain.
Featured In Orthopaedics
Lab Tests Predict Outcome of Two-Stage Exchange for Periprosthetic Joint Infection
Two-stage exchange arthroplasty is extremely costly and associated with high morbidity. Is it possible to identify patients at high-risk of failure?
Featured In Cardiovascular
Improved Identification of Patients at Risk for Atrial Fibrillation
Steve Lubitz, MD, MPH, discusses his team’s work focusing on understanding the mechanisms of atrial fibrillation through human genetics, and understanding how best to identify patients at risk for the arrhythmia.
Featured In Neuroscience
Prenatal Exposure to Folic Acid-fortified Foods May Reduce Mental Illness Risk
Fortification of grain-based foods with folic acid, a practice instituted in the U.S. in the 1990s to prevent neural tube defects in infants, may also reduce the incidence of severe mental illnesses like schizophrenia that initially appear in young adulthood.
Featured In Cardiovascular
Implementation of New Troponin Tests Aids Diagnosis of MI
Novel troponin blood tests help identify myocardial infarction earlier. An expert at Massachusetts General gives guidance for successful implementation.
The Latest Neurosciences Advances
Prenatal Exposure to Folic Acid-fortified Foods May Reduce Mental Illness Risk
Fortification of grain-based foods with folic acid, a practice instituted in the U.S. in the 1990s to prevent neural tube defects in infants, may also reduce the incidence of severe mental illnesses like schizophrenia that initially appear in young adulthood.
Managing Spinal Osteosarcoma After Subtotal Resection
Because primary osteosarcoma of the spine is so rare, little is known about how to manage residual or recurrent disease after initial therapy. Mass General researchers conducted a systematic review and meta-analysis that provide guidance.
Contributing Physicians
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine
John H. Shin, MD
Director, Metastatic Spine Oncology and Spinal Deformity Surgery (Mass General Cancer Center), Spinal Reconstruction Surgery
Advances Specialties
Cardiovascular
Routine Test May help Find ICI-Related Myocarditis Early
Myocarditis related to immune checkpoint inhibitors may be identified early through EKG and Troponin tests and treated with high dose steroids
Orthopaedics
Injury to Deltoid Ligament Appears Capable of Destabilizing the Syndesmosis
Researchers at Massachusetts General Hospital recently became the first to use arthroscopy to study the effects of deltoid ligament (DL) injury on syndesmotic stability.
October 13-14, 2018
CME: Cardiovascular Disease in Women: Update on Management of Pregnancy and Spontaneous Coronary Artery Dissection
This two-day course is dedicated to educating frontline caregivers with up-to-date diagnosis and management of women with cardiovascular conditions during pregnancy. A second day is dedicated to the workup and management of patients with coronary artery dissection.
September 28-29, 2018
CME: Short-term Mechanical Support Heart/Lung Symposium 2018
This course is designed to provide the fundamentals of the management of short-term support through multidisciplinary case scenarios to narrow the professional practice gap.
Mechanism of Action Electroconvulsive Therapy (ECT)
Are you planning on receiving ECT treatments for depression? Are you interested in getting an MRI scan of your brain? If you answered yes, then you are one step closer to being involved in our research study.
The "RADIANCE-HTN" Study: A study of the ReCor Medical Paradise System in Clinical Hypertension
The purpose of this clinical study is to see whether a medical device called the Paradise Renal Denervation System can safely reduce high blood pressure in patients who are known to have hypertension.
